Observational studyRespiratory research2021

Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis.

Manon Belhassen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.